These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 6416016

  • 1. Second-trimester abortion by extra-amniotic instillation of Rivanol combined with intravenous administration of oxytocin or prostaglandin F2 alpha.
    Klinte I, Hamberger L, Wiqvist N.
    Acta Obstet Gynecol Scand; 1983; 62(4):303-6. PubMed ID: 6416016
    [Abstract] [Full Text] [Related]

  • 2. Comparison of extra-amniotic instillation of rivanol and PGF2alpha either separately or in combination followed by oxytocin for second trimester abortion.
    Olund A, Larsson B.
    Acta Obstet Gynecol Scand; 1978; 57(4):333-6. PubMed ID: 358728
    [Abstract] [Full Text] [Related]

  • 3. Intrauterine administration of drugs for termination of pregnancy in the second trimester.
    Toppozada M, Ismail AA.
    Baillieres Clin Obstet Gynaecol; 1990 Jun; 4(2):327-49. PubMed ID: 2225603
    [Abstract] [Full Text] [Related]

  • 4. Prostaglandins and thromboxanes in amniotic fluid during rivanol-induced abortion and labour.
    Olund A, Kindahl H, Oliw E, Lindgren JA, Larsson B.
    Prostaglandins; 1980 May; 19(5):791-803. PubMed ID: 6775353
    [Abstract] [Full Text] [Related]

  • 5. Abortion during mid-pregnancy by rivanol-catheter supplemented with PGF2 alpha drip-infusion or quinine hydrocholoride.
    Manabe Y, Manabe A.
    Contraception; 1981 Jun; 23(6):621-8. PubMed ID: 6793303
    [Abstract] [Full Text] [Related]

  • 6. Mid-trimester abortion with intra-amniotic prostaglandin F2 alpha and intravenous oxytocin infusion.
    Salomy M, Halbrecht I, London R.
    Prostaglandins; 1975 Feb; 9(2):271-9. PubMed ID: 1135439
    [Abstract] [Full Text] [Related]

  • 7. Prostaglandin-oxytocin induction of mid-trimester abortion complicated by grand mal-like seizures.
    Sederberg-Olsen J, Olsen CE.
    Acta Obstet Gynecol Scand; 1983 Feb; 62(1):79-81. PubMed ID: 6407273
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Prostaglandin-F2 alpha levels in normal saline-induced mid-trimester abortions.
    Chandra K, Gupta I, Dhawan V, Ganguly NK.
    Contraception; 1991 Jul; 44(1):99-106. PubMed ID: 1893705
    [Abstract] [Full Text] [Related]

  • 12. Lack of coagulation defects after the intraamniotic instillation of ethacridine (Rivanol) for second trimester abortion.
    Beller FK, Zimmermann RE, Winkler UH, Seitzer D, Holzgreve W.
    Arch Gynecol Obstet; 1988 Jul; 243(1):1-4. PubMed ID: 3408272
    [Abstract] [Full Text] [Related]

  • 13. Use of prostaglandin, hypertonic saline and oxytocin for second-trimester abortion.
    Muzsnai D, Kerenyi T.
    Eur J Obstet Gynecol Reprod Biol; 1979 Dec; 9(6):385-9. PubMed ID: 299462
    [Abstract] [Full Text] [Related]

  • 14. Termination of second trimester pregnancy with single intra-amniotic and extra-amniotic instillation of prostaglandin F2 alpha and 15-methyl prostaglandin F2 alpha.
    Sethi A, Jalnawalla SF.
    J Obstet Gynaecol India; 1979 Apr; 29(2):274-82. PubMed ID: 12335893
    [Abstract] [Full Text] [Related]

  • 15. Midtrimester induction of abortion: comparison of extraovular prostaglandin E2 and intra-amniotic prostaglandin F2 alpha.
    Lurie S, Katz Z, Insler V.
    Contraception; 1993 May; 47(5):475-81. PubMed ID: 8513674
    [Abstract] [Full Text] [Related]

  • 16. [Chemical methods of abortion].
    Schmidt-Matthiesen H.
    Arch Gynecol; 1979 Jul 20; 228(1-4):365-78. PubMed ID: 485368
    [Abstract] [Full Text] [Related]

  • 17. Letter: Intravenous prostaglandins and oxytocin for mid-trimester abortion.
    Coltart TM, Coe MJ.
    Lancet; 1975 Jan 18; 1(7899):173-4. PubMed ID: 46097
    [Abstract] [Full Text] [Related]

  • 18. [Termination of pregnancy in the 2nd trimester using intra-amniotic administration of prostaglandins].
    Krofta L, Calda P, Zizka Z, Parízek A, Hrusková H, Kapras J.
    Ceska Gynekol; 1998 Oct 18; 63(5):414-7. PubMed ID: 9818502
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.